Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7–9 years of age
Janet Rowan(Auckland City Hospital), William M. Hague(The University of Adelaide), Lindsay D. Plank(University of Auckland), Suzette Coat(The University of Adelaide), Victor Obolonkin(University of Auckland), Jun Lu(Guangdong Medical College), Elaine Rush(Auckland University of Technology)
Cited by 295
Related Papers
Metformin versus Insulin for the Treatment of Gestational Diabetes
|New England Journal of Medicine|2008|1.3k
Metformin in Gestational Diabetes: The Offspring Follow-Up (MiG TOFU)
|Diabetes Care|2011|385
An Early Pregnancy HbA1c ≥5.9% (41 mmol/mol) Is Optimal for Detecting Diabetes and Identifies Women at Increased Risk of Adverse Pregnancy Outcomes
|Diabetes Care|2014|239
Neurodevelopmental outcome at 2 years in offspring of women randomised to metformin or insulin treatment for gestational diabetes
|Archives of Disease in Childhood Fetal & Neonatal|2016|109
Is There a Role for HbA1c in Pregnancy?
|Current Diabetes Reports|2016|107